TXMD
TXMD
NASDAQ · Pharmaceuticals

Therapeuticsmd Inc

$2.03
+0.03 (+1.50%)
As of Jun 23, 5:30 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +485.2% upside
Low Target $7.57
Average Target $11.88
High Target $17.16
Current Price $2.03
Current
$2.03
Target
$11.88
$7.57 $11.88 avg $17.16
Scenario Analysis
Bear Case
$7.57
272.9%
Low target
Base Case
$11.88
+485.2%
Avg target
Bull Case
$17.16
+745.3%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$2.95
-31.2% from high
52-Week Low
$0.98
+106.9% from low
Target vs 52W High
$11.88
+302.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%